What is the market doing?
What the tape says about ARQT
Arcutis Biotherapeutics, Inc. is +45% over the past year while the S&P 500 is +20%: 25 points ahead of the market.
+45%
1-year return · S&P 500 +20%
- vs 200-day average
- −4.3%
vs 200-day average · below trend, but not far
- RSI (14)
- 39
RSI (14) · neutral
- Below its 52-week high
- 22%
Below its 52-week high
Details›
- Last close2026-09-08
- $24.36
- 1 monthS&P 500 −0.30%
- −7.8%
- 1 yearS&P 500 +20%
- +45%
- 5 yearsS&P 500 +85%
- +10%
- vs 50-day average$25.96
- −6.2%
- 52-week high
- $31.20
- 52-week low
- $15.32
- Annualised volatility
- 63%
| Year | Return |
|---|---|
| 2026 (year to date) | −16% |
| 2025 | +108% |
| 2024 | +331% |
| 2023 | −78% |
| 2022 | −29% |
| 2021 | −26% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 2 of 6 | +7.7% |
| Feb | 7 | 6 of 7 | +21% |
| Mar | 7 | 3 of 7 | −4.1% |
| Apr | 7 | 3 of 7 | +3.4% |
| May | 7 | 3 of 7 | −10% |
| Jun | 7 | 6 of 7 | +9.4% |
| Jul | 7 | 5 of 7 | +3.0% |
| Aug | 7 | 3 of 7 | −3.9% |
| Sep | 7 | 4 of 7 | −4.1% |
| Oct | 6 | 1 of 6 | −15% |
| Nov | 6 | 3 of 6 | +15% |
| Dec | 6 | 4 of 6 | +15% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.